Up-Regulation of MiRNA-125a-5p Inhibits Cell Proliferation and Increases EGFR-TKI Induced Apoptosis in Lung Cancer Cells

BACKGROUND: Despite the dramatic efficacy of erlotinib, an EGFR tyrosine kinase inhibitor (TKI), most of non-small cell lung cancer (NSCLC) patients ultimately acquire resistance to this agent. Different studies indicated that miRNA-125a-5p is down-regulated in human lung cancer cells and may functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jamal, Jamal, Molaee, Neda, Karami, Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062986/
https://www.ncbi.nlm.nih.gov/pubmed/31759360
http://dx.doi.org/10.31557/APJCP.2019.20.11.3361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062986/
https://www.ncbi.nlm.nih.gov/pubmed/31759360
http://dx.doi.org/10.31557/APJCP.2019.20.11.3361

Ejemplares similares